Structures by: Sowa H.
Total: 25
C17H17FN3O3,5(H2O),NA
C17H17FN3O3,5(H2O),NA
CrystEngComm (2009) 11, 7 1396
a=9.624(3)Å b=9.493(3)Å c=11.471(4)Å
α=89.643(6)° β=103.304(6)° γ=88.861(6)°
Ciprofloxacin
C17H18FN3O3
CrystEngComm (2009) 11, 7 1396
a=7.9606(2)Å b=8.5798(2)Å c=10.7739(3)Å
α=87.868(3)° β=85.153(2)° γ=88.212(1)°
2(C17H17FN3O3),10(H2O),2(Na)
2(C17H17FN3O3),10(H2O),2(Na)
CrystEngComm (2009) 11, 7 1396
a=11.065(10)Å b=13.155(12)Å c=13.879(12)Å
α=90.983(14)° β=98.941(14)° γ=93.181(14)°
C17H17.50F1N3O3,Na0.50,5(H2O)
C17H17.50F1N3O3,Na0.50,5(H2O)
CrystEngComm (2009) 11, 7 1396
a=9.452(3)Å b=9.591(4)Å c=11.233(6)Å
α=85.67(2)° β=99.62(2)° γ=93.74(2)°
C17H17FN3O3,5(H2O),NA
C17H17FN3O3,5(H2O),NA
CrystEngComm (2009) 11, 7 1396
a=9.547(7)Å b=9.870(7)Å c=11.109(12)Å
α=88.79(4)° β=101.42(4)° γ=90.25(2)°
C17H17.50F1N3O3,Na0.50,5(H2O)
C17H17.50F1N3O3,Na0.50,5(H2O)
CrystEngComm (2009) 11, 7 1396
a=9.391(8)Å b=9.570(8)Å c=11.095(9)Å
α=85.247(14)° β=99.498(13)° γ=93.272(14)°
C9H17NO2,7(H2O)
C9H17NO2,7(H2O)
CrystEngComm (2010) 12, 8 2354
a=6.7906(12)Å b=7.3159(4)Å c=15.8428(14)Å
α=86.297(6)° β=78.924(11)° γ=72.713(6)°
Cyanocobalamin hydrate
C63H88CoN14O14P,23.5H2O
CrystEngComm (2010) 12, 9 2541
a=15.8260(9)Å b=22.4438(13)Å c=25.4429(16)Å
α=90.00° β=90.00° γ=90.00°
Cyanocobalamin hydrate
C63H88CoN14O14P,22H2O
CrystEngComm (2010) 12, 9 2541
a=15.9455(4)Å b=21.0511(5)Å c=23.8739(8)Å
α=90.00° β=90.00° γ=90.00°
F6NaSb
F6NaSb
Acta Crystallographica Section B (1997) 53, 1 25-31
a=8.198(2)Å b=8.198(2)Å c=8.198(2)Å
α=90.0° β=90.0° γ=90.0°
Zinc_oxide
OZn
Journal of Applied Crystallography (2006) 39, 2 169-175
a=3.2342(2)Å b=3.2342(2)Å c=5.1772(3)Å
α=90.00° β=90.00° γ=120.00°
Zinc_oxide
OZn
Journal of Applied Crystallography (2006) 39, 2 169-175
a=3.2190(3)Å b=3.2190(3)Å c=5.1489(3)Å
α=90.00° β=90.00° γ=120.00°
Zinc_oxide
OZn
Journal of Applied Crystallography (2006) 39, 2 169-175
a=3.2494(2)Å b=3.2494(2)Å c=5.2054(2)Å
α=90.00° β=90.00° γ=120.00°
Zinc_oxide
OZn
Journal of Applied Crystallography (2006) 39, 2 169-175
a=3.2049(3)Å b=3.2049(3)Å c=5.1216(4)Å
α=90.00° β=90.00° γ=120.00°
Zinc_oxide
OZn
Journal of Applied Crystallography (2006) 39, 2 169-175
a=3.1950(3)Å b=3.1950(3)Å c=5.1027(4)Å
α=90.00° β=90.00° γ=120.00°
L-serine III
C3H7NO3
Acta Crystallographica Section E (2006) 62, 9 o4052-o4054
a=5.6117(9)Å b=6.556(2)Å c=9.5321(12)Å
α=90.00° β=90.00° γ=90.00°
Ciprofloxacin--2,2-difluoroethanol (2/3)
2(C17H18FN3O3),3(C2H4F2O)
Acta Crystallographica Section C (2011) 67, 3 o120-o124
a=10.9848(4)Å b=13.9800(4)Å c=13.9802(4)Å
α=105.6488(18)° β=90.352(2)° γ=93.364(2)°
Ciprofloxacin--water (3/14.5)
3(C17H18FN3O3),14.5(H2O)
Acta Crystallographica Section C (2011) 67, 3 o120-o124
a=13.8760(12)Å b=15.8760(13)Å c=16.528(2)Å
α=115.755(7)° β=103.610(7)° γ=102.325(5)°
Dy0.028Er0.018Gd0.007H4O6PY0.947
Dy0.028Er0.018Gd0.007H4O6PY0.947
Acta Crystallographica Section C (1994) 50, 1651-1652
a=5.5780(10)Å b=15.006(3)Å c=6.275(2)Å
α=90° β=117.83(2)° γ=90°
Churchite-(Y)
Dy0.028Er0.018Gd0.007H4O6PY0.947
Acta Crystallographica, Section C (1994) 50, 1651-1652
a=5.578Å b=15.006Å c=6.275Å
α=90° β=117.83° γ=90°
Alarsite
AlAsO4
Zeitschrift fur Kristallographie (1991) 194, 291-304
a=5.028Å b=5.028Å c=11.228Å
α=90° β=90° γ=120°
Alarsite
AlAsO4
Zeitschrift fur Kristallographie (1991) 194, 291-304
a=5.030Å b=5.030Å c=11.234Å
α=90° β=90° γ=120°
Alarsite
AlAsO4
Zeitschrift fur Kristallographie (1991) 194, 291-304
a=4.945Å b=4.945Å c=11.135Å
α=90° β=90° γ=120°
Alarsite
AlAsO4
Zeitschrift fur Kristallographie (1991) 194, 291-304
a=4.873Å b=4.873Å c=11.071Å
α=90° β=90° γ=120°
Alarsite
AlAsO4
Zeitschrift fur Kristallographie (1991) 194, 291-304
a=4.799Å b=4.799Å c=11.003Å
α=90° β=90° γ=120°